Health Canada

Safety and security considerations when producing cannabis for your own medical purposes.

Regulations under the Cannabis Act set out the rules and standards that apply to the production, distribution, sale, importation and exportation of cannabis by federal licence holders.

Cannabis contains substances that affect the brain and body, including THC and CBD. THC causes the intoxicating effects of cannabis. CBD is not intoxicating and may reduce some of the effects of THC; however, it does have an effect on the brain.

Cannabis is not an approved therapeutic product and the provision of this information should not be interpreted as an endorsement of the use of cannabis for therapeutic purposes, or of marijuana generally, by Health Canada. This leaflet is designed by Health Canada for patients authorized to...

The purpose of this document is to provide guidance to holders of a licence under the Cannabis Act (hereafter referred to as licence holders) on the application of Part 4: Physical Security Measures of the Cannabis Regulations. It is designed to help licence holders understand the physical...

Mandatory cannabis health warning messages to be used on cannabis products by federal licence holders.

The limits set out in the tables below apply to the declared net weight and volume of cannabis that are required to appear on the labels of cannabis products in accordance with section 133 of the Cannabis Regulations.

Health Canada medical document form

For the purpose of your security clearance application, a Canadian police force, the Royal Canadian Mounted Police (RCMP), or private fingerprinting agencies accredited by the RCMP can submit, on your behalf, your fingerprints electronically to the RCMP for the purpose of a criminal record check.

Pursuant to section 56 of the CDSA and subject to the terms and conditions set out herein, applicants for a producer’s licence are exempted from the requirement in paragraph 33(1)(h) to provide a detailed description of security measures determined in accordance with the Security Directive in...

The purpose of this webpage is to help Canadian differentiate between legal and illegal cannabis products and find legal cannabis retailers in each province or territory.

You can submit questions and concerns about a cannabis site, product, service, accessory, promotion, or other aspects of laws and regulations regarding cannabis. Please review the table below, and direct your enquiry where appropriate.

If a person wants to use cannabis for medical purposes, the first step is to visit a health care practitioner. A health care practitioner will assess the person to determine if cannabis is an appropriate option for him/her. If the health care practitioner determines that cannabis is an...

Consultation on the Proposed Approach to the Regulation of Cannabis.

In November 2017, Health Canada published a consultation paper entitled Proposed Approach to the Regulation of Cannabis.

To support implementation of the proposed Act, regulations would need to be enacted in a range of areas, such as cannabis product standards and packaging and labelling requirements, to ensure that the risks and harms of cannabis are appropriately addressed under the legal framework.

The Access to Cannabis for Medical Purposes Regulations (ACMPR) provide the legal means through which Canadians can obtain access to cannabis for medical purposes, except as noted below (see section regarding the injunction). Under section 15 of the ACMPR, any individual who possesses or produces...

The Access to Cannabis for Medical Purposes Regulations provide a mechanism for patients to access cannabis for medical purposes with the support of their physician or nurse practitioner (where authorized by provincial regulatory authorities).

This document has been prepared by the Cannabis Legalization and Regulation Branch at Health Canada to provide information on the use of cannabis (marihuana) and cannabinoids for medical purposes. This document is a summary of peer-reviewed literature and international reviews concerning...

The following section provides the requirements for a CTA involving the use of pharmaceutical, biological, and radiopharmaceutical drugs. The requirements are the same for these drug products with a few exceptions.